Sotera Health (NASDAQ:SHC - Get Free Report) issued its earnings results on Thursday. The company reported $0.19 earnings per share for the quarter, missing analysts' consensus estimates of $0.21 by ($0.02), Zacks reports. Sotera Health had a return on equity of 42.27% and a net margin of 6.31%. The business had revenue of $290.20 million for the quarter, compared to analyst estimates of $291.37 million. Sotera Health updated its FY 2025 guidance to 0.700-0.760 EPS.
Sotera Health Price Performance
Shares of NASDAQ:SHC traded down $0.79 on Monday, reaching $11.68. 2,427,078 shares of the company traded hands, compared to its average volume of 1,015,204. The company has a debt-to-equity ratio of 4.91, a current ratio of 2.88 and a quick ratio of 2.61. Sotera Health has a fifty-two week low of $10.71 and a fifty-two week high of $17.08. The stock has a market capitalization of $3.31 billion, a PE ratio of 46.72 and a beta of 1.91. The company's 50 day moving average is $13.42 and its 200-day moving average is $14.48.
Wall Street Analysts Forecast Growth
SHC has been the subject of a number of research reports. Citigroup lifted their target price on Sotera Health from $18.00 to $20.00 and gave the company a "buy" rating in a research note on Wednesday, November 6th. Royal Bank of Canada restated an "outperform" rating and set a $17.00 price objective on shares of Sotera Health in a research note on Thursday, November 21st. The Goldman Sachs Group started coverage on shares of Sotera Health in a research note on Friday, December 6th. They set a "neutral" rating and a $14.00 target price for the company. Finally, Barclays decreased their price target on Sotera Health from $17.00 to $16.00 and set an "overweight" rating for the company in a research note on Friday. Two investment analysts have rated the stock with a hold rating and four have given a buy rating to the company's stock. According to MarketBeat.com, Sotera Health presently has an average rating of "Moderate Buy" and an average target price of $15.92.
Get Our Latest Stock Report on SHC
About Sotera Health
(
Get Free Report)
Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.
See Also
Before you consider Sotera Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sotera Health wasn't on the list.
While Sotera Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
